Introduction DayOne conference 2019
•
1 j'aime•316 vues
Presentation to introduce the DayOne Conference 2019 Shaping the future of Health.
Recommandé
Recommandé
Contenu connexe
Tendances
Tendances (20)
Similaire à Introduction DayOne conference 2019
Similaire à Introduction DayOne conference 2019 (20)
Plus de DayOne
Plus de DayOne (20)
Dernier
Dernier (20)
Introduction DayOne conference 2019
- 2. DayOne Conference 2019 FHNW, Muttenz September 9 Shaping the future of health
- 3. 3 Patients 18 panellists and speakers 30 projects and entrepreneurs 30 mentors 40 volunteers 450 participants 1 big open innovation workshop 1 digital health futurist
- 4. #DayOneBasel
- 5. DayOne Conference 2019 – Agenda for the morning 9.00 Welcome and Intro 9:15 Patient’s Panel 9:45 Session 1 “The Ethics of breaking the rules” 10:45 Networking Coffee Break and Exhibition 11:10 Session 2 “Financing – beyond venture capital?” 12:15 Networking Lunch Break and Exhibition
- 6. DayOne Conference 2019 – Agenda for the afternoon 13.15 Welcome and Intro 13:30 Pitching Session 14:15 Workshop session 16:00 Networking Coffee 16:20 Grand finale with Digital Health Futurist Maneesh Juneja 17:30 Networking Apero and Exhibition
- 7. Thomas Brenzikofer, Co-Founder DayOne BaselArea.swiss
- 8. Prof. Dr. Falko Schlottig Director of School of Life Sciences FHNW
- 10. 10 A growing community of 1500+ healthcare innovatiors
- 11. DayOne Core Team & Management Michael Rebhan, Novartis Peter Groenen, Idorsia Alain Bindels, Roche Torsten Schwede, University of Basel and Swiss Institute of Bioinformatics Christian Elias Schneider, University of Basel Andreas Wicki, Bram Stieltjes University Hospital Basel Nicole Probst-Hensch, Melissa Penny, Swiss TPH Erik Schkommodau, Enkelejda Miho, School of Life Sciences FHNW Christian Bosshard, CSEM Laurenz Baltzer, KARGER André Moeri, Medgate Rocco Falcetto, Patient Andrea Huber Brösamle, Niko Beerenwinkel, ETH DBSSE DayOne Team @ BAS: Frank Kumli Fabian Streiff Thomas Brenzikofer Douglas Häggström Stefano Glauser Mariela Salas Adrian Sprenger Supporters: Bhupinder Bhullar Viktor Bullain Aurelie Moser Egle Thomas Bejal Joshi
- 12. DayOne Partners MANAGED BY SUPPORTING PARTNERS KNOWLEDGE PARTNERS IN CLOSE COLLABORATION WITH CONFERENCE PARTNERS
- 13. 14 Vision Create a world leading hub for healthcare innovation, built on the strength of the Basel region respected for its impact facilitating collaboration across disciplines and industries with a focus on precision medicine – the convergence of diagnostics, treatment and digital health
- 14. shaping the future of health
- 35. Are we ready for this?
- 36. Nicholetta Iacobacci, Exponential Ethics Evelyne Bischof, Shanghai Jiao Tong University School of Medicine Bram Stieltjes, Universitätsspital Basel Judith Safford, Patient Daniel R. Karlin, HealthMode Athula Herath, Novartis Erik Schkommodau, FHNW
- 37. Who is going to pay for it?
- 38. Andreas Igel, Arcondis Julien de Salaberry, Galen Growth Alex Buech, Medical Insights Jan Vichr, Canopei Sybille Fischer, Baloise Gabor Szinnai, UKBB Stephanie Bova, Takeda Amine Korchi, Fusion André Guedel, KPMG
- 39. We have to make it happen!
- 40. Healthcare innovation projects in context
- 41. For whom are we doing this?
- 42. For Patients!
- 43. Cecile Tardy Judith Safford Peter Loewenberg
- 44. Fabian Streiff, Director DayOne BaselArea.swiss
- 45. 46
- 47. Nicholetta Iacobacci, Exponential Ethics Evelyne Bischof, Shanghai Jiao Tong University School of Medicine Bram Stieltjes, Universitätsspital Basel Daniel R. Karlin, HealthMode Pierre-Mikael Legris, pryv.com Athula Herath, Novartis Soenke Bartling, blockchain for science Erik Schkommodau, FHNW
- 48. Dürrenmatt • Who is struggling with data availability in Medicine? • Who has read Durrenmatt's Physicists? “What is thought, cannot be undone” …and will inevitably lead to its ultimate thinkable consequence
- 49. Is Dürrenmatt too sinister? Atomic energy, Atomic bomb, Atomic warfare
- 50. Questions • Should we stop ourselves? • Can we stop ourselves? • Regulations vs. moral standard • Global vs. local actions
- 51. Considerations • We will suffer from a status quo bias!1 Bostrom et al., Ethics 2006 • Contributing data vs money (sharing is no option) • Counteract neo-liberal thinking when it comes to healthcare • Use technology to make this shift efficient
- 52. Nicholetta Iacobacci, Exponential Ethics Evelyne Bischof, Shanghai Jiao Tong University School of Medicine Bram Stieltjes, Universitätsspital Basel Daniel R. Karlin, HealthMode Athula Herath, Novartis Erik Schkommodau, FHNW
- 61. Andreas Igel, Arcondis Julien de Salaberry, Galen Growth Alex Buech, Medical Insights Jan Vichr, Canopei Sybille Fischer, Baloise Gabor Szinnai, UKBB Stephanie Bova, Takeda Amine Korchi, Fusion André Guedel, KPMG
- 62. Andreas Igel, Arcondis Julien de Salaberry, Galen Growth Alex Buech, Medical Insights Jan Vichr, Canopei Sybille Fischer, Baloise Gabor Szinnai, UKBB Stephanie Bova, Takeda Amine Korchi, Fusion André Guedel, KPMG
- 63. Doug Häggström, DayOne Acceleration Lead BaselArea.swiss
- 65. Gabor Szinnai University Children’s Hospital Basel (UKBB)
- 66. Maneesh Juneja Digital Health Futurist
- 67. DayOne Conference 2019 FHNW, Muttenz September 9 Shaping the future of health